Global Unit Case Volume Grew 1%
Net Revenues Grew 3%;
Organic Revenues Grew 11%
Operating Income Declined 36%;
Comparable Currency Neutral Operating Income Grew 13%
Operating Margin Was 18.9%.
– Total revenues of $881 million in the first quarter
– Jakafi® net product revenues of $572 million in Q1 24, total paid patients increased +5% Y/Y; reiterating full year 2024 guidance of.
First quarter results reflect continued strong semiconductor and data center demand growthClearwater Wind Development placed into service in January, providing geographic resource diversity and 311.
T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.